{"transactions":[{"id":944974,"issuer":{"id":5337,"kind":"organization","name":"CAPRICOR THERAPEUTICS, INC."},"owners":[{"id":69869,"kind":"person","name":"Musket David B","position":1,"cik":"0001310611","reported_name":"Musket David B","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2026-01-07T21:45:14.000Z","date":"2026-01-05","kind":"grant","planned":false,"acquired":true,"shares":15500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares vest 1/12th of the first day of each month, commencing February 1, 2026, with the last month vesting on December 31, 2026, until the stock option becomes fully vested and exercisable. The award pertains to annual board service. The option is subject to early exercise and, therefore, all or any part of the option can be exercised at any time. If the reporting person elects to take advantage of the early exercise feature and purchase shares prior to the vesting of such shares, the shares will be deemed restricted stock and will be subject to a repurchase option in favor of the Issuer if the reporting person's service to the Issuer terminates prior to vesting."}],"balance_after":15500,"derivative":{"exercise_price":24.81,"expiration_date":"2036-01-05","underlying":"Common Stock","underlying_shares":15500},"source":{"system":"sec-edgar","filing":"0001310611-26-000002","document":"form4-01072026_040111.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1133869/000131061126000002/form4-01072026_040111.xml","form_type":"4"}},{"id":1311429,"issuer":{"id":5337,"kind":"organization","name":"CAPRICOR THERAPEUTICS, INC."},"owners":[{"id":69869,"kind":"person","name":"Musket David B","position":1,"cik":"0001310611","reported_name":"Musket David B","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2025-01-07T00:00:14.000Z","date":"2025-01-02","kind":"grant","planned":false,"acquired":true,"shares":5750,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The shares of the award are fully vested and exercisable as of January 2, 2025, the date of the grant. The award pertains to annual board service."}],"balance_after":5750,"derivative":{"exercise_price":14.96,"expiration_date":"2035-01-02","underlying":"Common Stock","underlying_shares":5750},"source":{"system":"sec-edgar","filing":"0001415889-25-000870","document":"form4-01062025_070109.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1133869/000141588925000870/form4-01062025_070109.xml","form_type":"4"}},{"id":1311428,"issuer":{"id":5337,"kind":"organization","name":"CAPRICOR THERAPEUTICS, INC."},"owners":[{"id":69869,"kind":"person","name":"Musket David B","position":1,"cik":"0001310611","reported_name":"Musket David B","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2025-01-07T00:00:14.000Z","date":"2025-01-02","kind":"grant","planned":false,"acquired":true,"shares":6480,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The shares of the award are fully vested and exercisable as of January 2, 2025, the date of the grant. The award pertains to annual board committee service."}],"balance_after":6480,"derivative":{"exercise_price":14.96,"expiration_date":"2035-01-02","underlying":"Common Stock","underlying_shares":6480},"source":{"system":"sec-edgar","filing":"0001415889-25-000870","document":"form4-01062025_070109.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1133869/000141588925000870/form4-01062025_070109.xml","form_type":"4"}},{"id":1311427,"issuer":{"id":5337,"kind":"organization","name":"CAPRICOR THERAPEUTICS, INC."},"owners":[{"id":69869,"kind":"person","name":"Musket David B","position":1,"cik":"0001310611","reported_name":"Musket David B","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2025-01-07T00:00:14.000Z","date":"2025-01-02","kind":"grant","planned":false,"acquired":true,"shares":11940,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares vest 1/12th of the first day of each month, commencing February 1, 2025, with the last month vesting on December 31, 2025, until the stock option becomes fully vested and exercisable. The award pertains to annual board service. The option is subject to early exercise and, therefore, all or any part of the option can be exercised at any time. If the reporting person elects to take advantage of the early exercise feature and purchase shares prior to the vesting of such shares, the shares will be deemed restricted stock and will be subject to a repurchase option in favor of the Issuer if the reporting person's service to the Issuer terminates prior to vesting."}],"balance_after":11940,"derivative":{"exercise_price":14.96,"expiration_date":"2035-01-02","underlying":"Common Stock","underlying_shares":11940},"source":{"system":"sec-edgar","filing":"0001415889-25-000870","document":"form4-01062025_070109.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1133869/000141588925000870/form4-01062025_070109.xml","form_type":"4"}},{"id":1437129,"issuer":{"id":5337,"kind":"organization","name":"CAPRICOR THERAPEUTICS, INC."},"owners":[{"id":69869,"kind":"person","name":"Musket David B","position":1,"cik":"0001310611","reported_name":"Musket David B","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2024-08-09T13:00:07.000Z","date":"2024-08-07","kind":"exercise","planned":false,"acquired":false,"shares":34000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares vested 1/48th of the first day of each month, commencing March 1, 2020."}],"balance_after":75000,"derivative":{"exercise_price":1.39,"expiration_date":"2030-06-05","underlying":"Common Stock","underlying_shares":34000},"source":{"system":"sec-edgar","filing":"0001415889-24-021022","document":"form4-08092024_090802.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1133869/000141588924021022/form4-08092024_090802.xml","form_type":"4"}},{"id":1437128,"issuer":{"id":5337,"kind":"organization","name":"CAPRICOR THERAPEUTICS, INC."},"owners":[{"id":69869,"kind":"person","name":"Musket David B","position":1,"cik":"0001310611","reported_name":"Musket David B","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-08-09T13:00:07.000Z","date":"2024-08-07","kind":"exercise","planned":false,"acquired":true,"shares":34000,"price":1.39,"value":47260.0,"ownership":{"direct":true},"balance_after":81692,"source":{"system":"sec-edgar","filing":"0001415889-24-021022","document":"form4-08092024_090802.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1133869/000141588924021022/form4-08092024_090802.xml","form_type":"4"}},{"id":1536349,"issuer":{"id":5337,"kind":"organization","name":"CAPRICOR THERAPEUTICS, INC."},"owners":[{"id":69869,"kind":"person","name":"Musket David B","position":1,"cik":"0001310611","reported_name":"Musket David B","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2024-04-24T17:30:09.000Z","date":"2024-04-23","kind":"exercise","planned":false,"acquired":false,"shares":5750,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F9","text":"This option was granted on August 8, 2019 and was previously reported with an exercise price of $3.25 per share, but was adjusted to reflect a share reprice to $1.39 per share that occurred on February 12, 2020."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F10","text":"The shares vested 1/48th of the first day of each month, commencing September 1, 2019."}],"balance_after":0,"derivative":{"exercise_price":1.39,"expiration_date":"2029-08-08","underlying":"Common Stock","underlying_shares":5750},"source":{"system":"sec-edgar","filing":"0001415889-24-011416","document":"form4-04242024_010401.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1133869/000141588924011416/form4-04242024_010401.xml","form_type":"4"}},{"id":1536348,"issuer":{"id":5337,"kind":"organization","name":"CAPRICOR THERAPEUTICS, INC."},"owners":[{"id":69869,"kind":"person","name":"Musket David B","position":1,"cik":"0001310611","reported_name":"Musket David B","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2024-04-24T17:30:09.000Z","date":"2024-04-23","kind":"exercise","planned":false,"acquired":false,"shares":3000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F9","text":"This option was granted on August 8, 2019 and was previously reported with an exercise price of $3.25 per share, but was adjusted to reflect a share reprice to $1.39 per share that occurred on February 12, 2020."}],"balance_after":0,"derivative":{"exercise_price":1.39,"exercise_date":"2019-08-08","expiration_date":"2029-08-08","underlying":"Common Stock","underlying_shares":3000},"source":{"system":"sec-edgar","filing":"0001415889-24-011416","document":"form4-04242024_010401.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1133869/000141588924011416/form4-04242024_010401.xml","form_type":"4"}},{"id":1536347,"issuer":{"id":5337,"kind":"organization","name":"CAPRICOR THERAPEUTICS, INC."},"owners":[{"id":69869,"kind":"person","name":"Musket David B","position":1,"cik":"0001310611","reported_name":"Musket David B","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2024-04-24T17:30:09.000Z","date":"2024-04-23","kind":"exercise","planned":false,"acquired":false,"shares":2750,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F7","text":"This option was granted on January 2, 2018 and was previously reported as covering 27,500 shares at an exercise price of $1.57 per share, but was adjusted to reflect a 1-for-10 reverse stock split that occurred on June 4, 2019 and a share reprice to $1.39 per share that occurred on February 12, 2020."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F8","text":"The shares vested 1/12th of the first day of each month, commencing February 1, 2018 with the last 1/12th vesting on December 31, 2018."}],"balance_after":0,"derivative":{"exercise_price":1.39,"expiration_date":"2028-01-02","underlying":"Common Stock","underlying_shares":2750},"source":{"system":"sec-edgar","filing":"0001415889-24-011416","document":"form4-04242024_010401.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1133869/000141588924011416/form4-04242024_010401.xml","form_type":"4"}},{"id":1536346,"issuer":{"id":5337,"kind":"organization","name":"CAPRICOR THERAPEUTICS, INC."},"owners":[{"id":69869,"kind":"person","name":"Musket David B","position":1,"cik":"0001310611","reported_name":"Musket David B","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2024-04-24T17:30:09.000Z","date":"2024-04-23","kind":"exercise","planned":false,"acquired":false,"shares":1050,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F5","text":"This option was granted on January 2, 2018 and was previously reported as covering 10,500 shares at an exercise price of $1.57 per share, but was adjusted to reflect a 1-for-10 reverse stock split that occurred on June 4, 2019 and a share reprice to $1.39 per share that occurred on February 12, 2020."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"The shares vested 1/48th of the first day of each month, commencing February 1, 2018."}],"balance_after":0,"derivative":{"exercise_price":1.39,"expiration_date":"2028-01-02","underlying":"Common Stock","underlying_shares":1050},"source":{"system":"sec-edgar","filing":"0001415889-24-011416","document":"form4-04242024_010401.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1133869/000141588924011416/form4-04242024_010401.xml","form_type":"4"}},{"id":1536345,"issuer":{"id":5337,"kind":"organization","name":"CAPRICOR THERAPEUTICS, INC."},"owners":[{"id":69869,"kind":"person","name":"Musket David B","position":1,"cik":"0001310611","reported_name":"Musket David B","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2024-04-24T17:30:09.000Z","date":"2024-04-23","kind":"exercise","planned":false,"acquired":false,"shares":2750,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"This option was granted on January 3, 2017 and was previously reported as covering 27,500 shares at an exercise price of $2.55 per share, but was adjusted to reflect a 1-for-10 reverse stock split that occurred on June 4, 2019 and a share reprice to $1.39 per share that occurred on February 12, 2020."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The shares vested 1/12th of the first day of each month, commencing February 1, 2017 with the last 1/12th vesting on December 31, 2017."}],"balance_after":0,"derivative":{"exercise_price":1.39,"expiration_date":"2027-01-03","underlying":"Common Stock","underlying_shares":2750},"source":{"system":"sec-edgar","filing":"0001415889-24-011416","document":"form4-04242024_010401.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1133869/000141588924011416/form4-04242024_010401.xml","form_type":"4"}},{"id":1536344,"issuer":{"id":5337,"kind":"organization","name":"CAPRICOR THERAPEUTICS, INC."},"owners":[{"id":69869,"kind":"person","name":"Musket David B","position":1,"cik":"0001310611","reported_name":"Musket David B","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2024-04-24T17:30:09.000Z","date":"2024-04-23","kind":"exercise","planned":false,"acquired":false,"shares":856,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"This option was granted on January 3, 2017 and was previously reported as covering 8,560 shares at an exercise price of $2.55 per share, but was adjusted to reflect a 1-for-10 reverse stock split that occurred on June 4, 2019 and a share reprice to $1.39 per share that occurred on February 12, 2020."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The shares vested 1/48th of the first day of each month, commencing February 1, 2017."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F1","text":"This option was granted on January 3, 2017 and was previously reported as covering 8,560 shares at an exercise price of $2.55 per share, but was adjusted to reflect a 1-for-10 reverse stock split that occurred on June 4, 2019 and a share reprice to $1.39 per share that occurred on February 12, 2020."}],"balance_after":0,"derivative":{"exercise_price":1.39,"expiration_date":"2027-01-03","underlying":"Common Stock","underlying_shares":856},"source":{"system":"sec-edgar","filing":"0001415889-24-011416","document":"form4-04242024_010401.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1133869/000141588924011416/form4-04242024_010401.xml","form_type":"4"}},{"id":1536343,"issuer":{"id":5337,"kind":"organization","name":"CAPRICOR THERAPEUTICS, INC."},"owners":[{"id":69869,"kind":"person","name":"Musket David B","position":1,"cik":"0001310611","reported_name":"Musket David B","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-04-24T17:30:09.000Z","date":"2024-04-23","kind":"exercise","planned":false,"acquired":true,"shares":16156,"price":1.39,"value":22456.84,"ownership":{"direct":true},"balance_after":47692,"source":{"system":"sec-edgar","filing":"0001415889-24-011416","document":"form4-04242024_010401.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1133869/000141588924011416/form4-04242024_010401.xml","form_type":"4"}},{"id":1688593,"issuer":{"id":5337,"kind":"organization","name":"CAPRICOR THERAPEUTICS, INC."},"owners":[{"id":69869,"kind":"person","name":"Musket David B","position":1,"cik":"0001310611","reported_name":"Musket David B","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2024-01-04T22:15:31.000Z","date":"2024-01-02","kind":"grant","planned":false,"acquired":true,"shares":14280,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The shares of the award are fully vested and exercisable as of January 2, 2024, the date of the grant. The award pertains to annual board service."}],"balance_after":14280,"derivative":{"exercise_price":5.12,"expiration_date":"2034-01-02","underlying":"Common Stock","underlying_shares":14280},"source":{"system":"sec-edgar","filing":"0001415889-24-000654","document":"form4-01042024_050114.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1133869/000141588924000654/form4-01042024_050114.xml","form_type":"4"}},{"id":1688592,"issuer":{"id":5337,"kind":"organization","name":"CAPRICOR THERAPEUTICS, INC."},"owners":[{"id":69869,"kind":"person","name":"Musket David B","position":1,"cik":"0001310611","reported_name":"Musket David B","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2024-01-04T22:15:31.000Z","date":"2024-01-02","kind":"grant","planned":false,"acquired":true,"shares":15170,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The shares of the award are fully vested and exercisable as of January 2, 2024, the date of the grant. The award pertains to annual board committee service."}],"balance_after":15170,"derivative":{"exercise_price":5.12,"expiration_date":"2034-01-02","underlying":"Common Stock","underlying_shares":15170},"source":{"system":"sec-edgar","filing":"0001415889-24-000654","document":"form4-01042024_050114.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1133869/000141588924000654/form4-01042024_050114.xml","form_type":"4"}},{"id":1688591,"issuer":{"id":5337,"kind":"organization","name":"CAPRICOR THERAPEUTICS, INC."},"owners":[{"id":69869,"kind":"person","name":"Musket David B","position":1,"cik":"0001310611","reported_name":"Musket David B","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2024-01-04T22:15:31.000Z","date":"2024-01-02","kind":"grant","planned":false,"acquired":true,"shares":29250,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares vest 1/12th of the first day of each month, commencing February 1, 2024, with the last month vesting on December 31, 2024, until the stock option becomes fully vested and exercisable. The award pertains to annual board service. The option is subject to early exercise and, therefore, all or any part of the option can be exercised at any time. If the reporting person elects to take advantage of the early exercise feature and purchase shares prior to the vesting of such shares, the shares will be deemed restricted stock and will be subject to a repurchase option in favor of the Issuer if the reporting person's service to the Issuer terminates prior to vesting."}],"balance_after":29250,"derivative":{"exercise_price":5.12,"expiration_date":"2034-01-02","underlying":"Common Stock","underlying_shares":29250},"source":{"system":"sec-edgar","filing":"0001415889-24-000654","document":"form4-01042024_050114.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1133869/000141588924000654/form4-01042024_050114.xml","form_type":"4"}},{"id":1760679,"issuer":{"id":5337,"kind":"organization","name":"CAPRICOR THERAPEUTICS, INC."},"owners":[{"id":69869,"kind":"person","name":"Musket David B","position":1,"cik":"0001310611","reported_name":"Musket David B","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-10-13T17:59:57.000Z","date":"2023-10-12","kind":"purchase","planned":false,"acquired":true,"shares":410,"price":2.75,"value":1127.5,"ownership":{"direct":true},"balance_after":31536,"source":{"system":"sec-edgar","filing":"0001415889-23-014199","document":"form4-10132023_051051.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1133869/000141588923014199/form4-10132023_051051.xml","form_type":"4"}},{"id":1761958,"issuer":{"id":5337,"kind":"organization","name":"CAPRICOR THERAPEUTICS, INC."},"owners":[{"id":69869,"kind":"person","name":"Musket David B","position":1,"cik":"0001310611","reported_name":"Musket David B","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-10-11T13:15:08.000Z","date":"2023-10-09","kind":"purchase","planned":false,"acquired":true,"shares":5083,"price":2.82,"value":14334.06,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $2.75 to $2.85, inclusive. The reporting person undertakes to provide to Capricor Therapeutics, Inc., any security holder of Capricor Therapeutics, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote."}],"balance_after":31126,"source":{"system":"sec-edgar","filing":"0001415889-23-014082","document":"form4-10112023_091002.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1133869/000141588923014082/form4-10112023_091002.xml","form_type":"4"}},{"id":1763874,"issuer":{"id":5337,"kind":"organization","name":"CAPRICOR THERAPEUTICS, INC."},"owners":[{"id":69869,"kind":"person","name":"Musket David B","position":1,"cik":"0001310611","reported_name":"Musket David B","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-10-06T13:15:07.000Z","date":"2023-10-04","kind":"purchase","planned":false,"acquired":true,"shares":2500,"price":2.9,"value":7250.0,"ownership":{"direct":true},"balance_after":26043,"source":{"system":"sec-edgar","filing":"0001415889-23-014031","document":"form4-10062023_091001.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1133869/000141588923014031/form4-10062023_091001.xml","form_type":"4"}},{"id":2063293,"issuer":{"id":5337,"kind":"organization","name":"CAPRICOR THERAPEUTICS, INC."},"owners":[{"id":69869,"kind":"person","name":"Musket David B","position":1,"cik":"0001310611","reported_name":"Musket David B","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2023-01-06T01:01:06.000Z","date":"2023-01-03","kind":"grant","acquired":true,"shares":19000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The shares of the award are fully vested and exercisable as of January 3, 2023, the date of the grant. The award pertains to annual board service."}],"balance_after":19000,"derivative":{"exercise_price":3.85,"expiration_date":"2033-01-03","underlying":"Common Stock","underlying_shares":19000},"source":{"system":"sec-edgar","filing":"0001415889-23-000596","document":"form4-01052023_080154.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1133869/000141588923000596/form4-01052023_080154.xml","form_type":"4"}},{"id":2063292,"issuer":{"id":5337,"kind":"organization","name":"CAPRICOR THERAPEUTICS, INC."},"owners":[{"id":69869,"kind":"person","name":"Musket David B","position":1,"cik":"0001310611","reported_name":"Musket David B","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2023-01-06T01:01:06.000Z","date":"2023-01-03","kind":"grant","acquired":true,"shares":16620,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The shares of the award are fully vested and exercisable as of January 3, 2023, the date of the grant. The award pertains to annual board committee service."}],"balance_after":16620,"derivative":{"exercise_price":3.85,"expiration_date":"2033-01-03","underlying":"Common Stock","underlying_shares":16620},"source":{"system":"sec-edgar","filing":"0001415889-23-000596","document":"form4-01052023_080154.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1133869/000141588923000596/form4-01052023_080154.xml","form_type":"4"}},{"id":2063291,"issuer":{"id":5337,"kind":"organization","name":"CAPRICOR THERAPEUTICS, INC."},"owners":[{"id":69869,"kind":"person","name":"Musket David B","position":1,"cik":"0001310611","reported_name":"Musket David B","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2023-01-06T01:01:06.000Z","date":"2023-01-03","kind":"grant","acquired":true,"shares":37770,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares vest 1/12th of the first day of each month, commencing February 1, 2023, with the last month vesting on December 31, 2023, until the stock option becomes fully vested and exercisable. The award pertains to annual board service. The option is subject to early exercise and, therefore, all or any part of the option can be exercised at any time. If the reporting person elects to take advantage of the early exercise feature and purchase shares prior to the vesting of such shares, the shares will be deemed restricted stock and will be subject to a repurchase option in favor of the Issuer if the reporting person's service to the Issuer terminates prior to vesting."}],"balance_after":37770,"derivative":{"exercise_price":3.85,"expiration_date":"2033-01-03","underlying":"Common Stock","underlying_shares":37770},"source":{"system":"sec-edgar","filing":"0001415889-23-000596","document":"form4-01052023_080154.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1133869/000141588923000596/form4-01052023_080154.xml","form_type":"4"}},{"id":2217566,"issuer":{"id":5337,"kind":"organization","name":"CAPRICOR THERAPEUTICS, INC."},"owners":[{"id":69869,"kind":"person","name":"Musket David B","position":1,"cik":"0001310611","reported_name":"Musket David B","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2022-07-02T01:00:16.000Z","date":"2022-06-30","kind":"exercise","acquired":false,"shares":4645,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F5","text":"This option was granted on June 2, 2016 and was previously reported as covering 46,458 shares at an exercise price of $3.12 per share, but was adjusted to reflect a 1-for-10 reverse stock split that occurred on June 4, 2019 and a share reprice to $1.39 per share that occurred on February 12, 2020."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"2,250 shares vested immediately on June 2, 2016. The remaining shares vested on December 31, 2016."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F5","text":"This option was granted on June 2, 2016 and was previously reported as covering 46,458 shares at an exercise price of $3.12 per share, but was adjusted to reflect a 1-for-10 reverse stock split that occurred on June 4, 2019 and a share reprice to $1.39 per share that occurred on February 12, 2020."}],"balance_after":0,"derivative":{"exercise_price":1.39,"expiration_date":"2026-06-02","underlying":"Common Stock","underlying_shares":4645},"source":{"system":"sec-edgar","filing":"0001415889-22-007219","document":"form4-07012022_090701.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1133869/000141588922007219/form4-07012022_090701.xml","form_type":"4"}},{"id":2217565,"issuer":{"id":5337,"kind":"organization","name":"CAPRICOR THERAPEUTICS, INC."},"owners":[{"id":69869,"kind":"person","name":"Musket David B","position":1,"cik":"0001310611","reported_name":"Musket David B","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2022-07-02T01:00:16.000Z","date":"2022-06-30","kind":"exercise","acquired":false,"shares":4750,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F4","text":"This option was granted on March 3, 2015 and was previously reported as covering 47,500 shares at an exercise price of $5.78 per share, but was adjusted to reflect a 1-for-10 reverse stock split that occurred on June 4, 2019 and a share reprice to $1.39 per share that occurred on February 12, 2020."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F4","text":"This option was granted on March 3, 2015 and was previously reported as covering 47,500 shares at an exercise price of $5.78 per share, but was adjusted to reflect a 1-for-10 reverse stock split that occurred on June 4, 2019 and a share reprice to $1.39 per share that occurred on February 12, 2020."}],"balance_after":0,"derivative":{"exercise_price":1.39,"exercise_date":"2015-03-03","expiration_date":"2025-03-03","underlying":"Common Stock","underlying_shares":4750},"source":{"system":"sec-edgar","filing":"0001415889-22-007219","document":"form4-07012022_090701.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1133869/000141588922007219/form4-07012022_090701.xml","form_type":"4"}},{"id":2217564,"issuer":{"id":5337,"kind":"organization","name":"CAPRICOR THERAPEUTICS, INC."},"owners":[{"id":69869,"kind":"person","name":"Musket David B","position":1,"cik":"0001310611","reported_name":"Musket David B","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2022-07-02T01:00:16.000Z","date":"2022-06-30","kind":"exercise","acquired":false,"shares":1401,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"This option was granted on February 22, 2013 and was previously reported as covering 14,015 shares at an exercise price of $0.37 per share, but was adjusted to reflect a 1-for-10 reverse stock split that occurred on June 4, 2019 and a share reprice to $1.39 per share that occurred on February 12, 2020."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"25% of the shares of common stock vested immediately, with the remainder vesting 1/36th of the first day of each month, commencing May 1, 2013."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F2","text":"This option was granted on February 22, 2013 and was previously reported as covering 14,015 shares at an exercise price of $0.37 per share, but was adjusted to reflect a 1-for-10 reverse stock split that occurred on June 4, 2019 and a share reprice to $1.39 per share that occurred on February 12, 2020."}],"balance_after":0,"derivative":{"exercise_price":1.39,"expiration_date":"2023-02-22","underlying":"Common Stock","underlying_shares":1401},"source":{"system":"sec-edgar","filing":"0001415889-22-007219","document":"form4-07012022_090701.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1133869/000141588922007219/form4-07012022_090701.xml","form_type":"4"}},{"id":2217563,"issuer":{"id":5337,"kind":"organization","name":"CAPRICOR THERAPEUTICS, INC."},"owners":[{"id":69869,"kind":"person","name":"Musket David B","position":1,"cik":"0001310611","reported_name":"Musket David B","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-07-02T01:00:16.000Z","date":"2022-06-30","kind":"exercise","acquired":true,"shares":10796,"price":1.39,"value":15006.44,"ownership":{"direct":true},"balance_after":23543,"source":{"system":"sec-edgar","filing":"0001415889-22-007219","document":"form4-07012022_090701.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1133869/000141588922007219/form4-07012022_090701.xml","form_type":"4"}},{"id":2217562,"issuer":{"id":5337,"kind":"organization","name":"CAPRICOR THERAPEUTICS, INC."},"owners":[{"id":69869,"kind":"person","name":"Musket David B","position":1,"cik":"0001310611","reported_name":"Musket David B","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-07-02T01:00:16.000Z","date":"2022-06-29","kind":"sale","acquired":false,"shares":28215,"price":3.77,"value":106370.55,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $3.76 to $3.80, inclusive. The reporting person undertakes to provide to Capricor Therapeutics, Inc., any security holder of Capricor Therapeutics, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote."}],"balance_after":12747,"source":{"system":"sec-edgar","filing":"0001415889-22-007219","document":"form4-07012022_090701.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1133869/000141588922007219/form4-07012022_090701.xml","form_type":"4"}},{"id":2219525,"issuer":{"id":5337,"kind":"organization","name":"CAPRICOR THERAPEUTICS, INC."},"owners":[{"id":69869,"kind":"person","name":"Musket David B","position":1,"cik":"0001310611","reported_name":"Musket David B","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-06-30T01:00:18.000Z","date":"2022-06-27","kind":"sale","acquired":false,"shares":17775,"price":4.44,"value":78921.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported on this Form 4 represents shares sold by the Reporting Person to partially cover tax obligations in connection to stock holdings."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $4.41 to $4.46, inclusive. The reporting person undertakes to provide to Capricor Therapeutics, Inc., any security holder of Capricor Therapeutics, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote."}],"balance_after":40962,"source":{"system":"sec-edgar","filing":"0001415889-22-007064","document":"form4-06292022_090601.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1133869/000141588922007064/form4-06292022_090601.xml","form_type":"4"}},{"id":2450294,"issuer":{"id":5337,"kind":"organization","name":"CAPRICOR THERAPEUTICS, INC."},"owners":[{"id":69869,"kind":"person","name":"Musket David B","position":1,"cik":"0001310611","reported_name":"Musket David B","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2022-01-05T02:00:52.000Z","date":"2022-01-03","kind":"grant","acquired":true,"shares":84080,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares vest 1/48th of the first day of each month, commencing February 1, 2022, until the stock option becomes fully vested and exercisable.  The option is subject to early exercise and, therefore, all or any part of the option can be exercised at any time. If the reporting person elects to take advantage of the early exercise feature and purchase shares prior to the vesting of such shares, the shares will be deemed restricted stock and will be subject to a repurchase option in favor of the Issuer if the reporting person's service to the Issuer terminates prior to vesting."}],"balance_after":84080,"derivative":{"exercise_price":3.18,"expiration_date":"2032-01-03","underlying":"Common Stock","underlying_shares":84080},"source":{"system":"sec-edgar","filing":"0001415889-22-000281","document":"form4-01042022_090140.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1133869/000141588922000281/form4-01042022_090140.xml","form_type":"4"}},{"id":2457325,"issuer":{"id":5337,"kind":"organization","name":"CAPRICOR THERAPEUTICS, INC."},"owners":[{"id":69869,"kind":"person","name":"Musket David B","position":1,"cik":"0001310611","reported_name":"Musket David B","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Warrants (Right to Buy)","published_at":"2021-12-29T14:00:15.000Z","date":"2021-12-27","kind":"exercise","acquired":false,"shares":20391,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":0,"derivative":{"exercise_price":1.1,"exercise_date":"2019-12-17","expiration_date":"2024-12-17","underlying":"Common Stock","underlying_shares":20391},"source":{"system":"sec-edgar","filing":"0001415889-21-006268","document":"form4-12292021_091205.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1133869/000141588921006268/form4-12292021_091205.xml","form_type":"4"}},{"id":2457324,"issuer":{"id":5337,"kind":"organization","name":"CAPRICOR THERAPEUTICS, INC."},"owners":[{"id":69869,"kind":"person","name":"Musket David B","position":1,"cik":"0001310611","reported_name":"Musket David B","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2021-12-29T14:00:15.000Z","date":"2021-12-27","kind":"exercise","acquired":false,"shares":15455,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"This option was granted on April 27, 2012 and was previously reported as covering 154,555 shares at an exercise price of $0.37 per share, but was adjusted to reflect a 1-for-10 reverse stock split that occurred on June 4, 2019 and a share reprice to $1.39 per share that occurred on February 12, 2020."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The shares vested 1/48th of the first day of each month, commencing May 1, 2012."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F1","text":"This option was granted on April 27, 2012 and was previously reported as covering 154,555 shares at an exercise price of $0.37 per share, but was adjusted to reflect a 1-for-10 reverse stock split that occurred on June 4, 2019 and a share reprice to $1.39 per share that occurred on February 12, 2020."}],"balance_after":0,"derivative":{"exercise_price":1.39,"expiration_date":"2022-04-27","underlying":"Common Stock","underlying_shares":15455},"source":{"system":"sec-edgar","filing":"0001415889-21-006268","document":"form4-12292021_091205.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1133869/000141588921006268/form4-12292021_091205.xml","form_type":"4"}},{"id":2457323,"issuer":{"id":5337,"kind":"organization","name":"CAPRICOR THERAPEUTICS, INC."},"owners":[{"id":69869,"kind":"person","name":"Musket David B","position":1,"cik":"0001310611","reported_name":"Musket David B","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-12-29T14:00:15.000Z","date":"2021-12-27","kind":"exercise","acquired":true,"shares":20391,"price":1.1,"value":22430.1,"ownership":{"direct":true},"balance_after":58737,"source":{"system":"sec-edgar","filing":"0001415889-21-006268","document":"form4-12292021_091205.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1133869/000141588921006268/form4-12292021_091205.xml","form_type":"4"}},{"id":2457322,"issuer":{"id":5337,"kind":"organization","name":"CAPRICOR THERAPEUTICS, INC."},"owners":[{"id":69869,"kind":"person","name":"Musket David B","position":1,"cik":"0001310611","reported_name":"Musket David B","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-12-29T14:00:15.000Z","date":"2021-12-27","kind":"exercise","acquired":true,"shares":15455,"price":1.39,"value":21482.45,"ownership":{"direct":true},"balance_after":38346,"source":{"system":"sec-edgar","filing":"0001415889-21-006268","document":"form4-12292021_091205.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1133869/000141588921006268/form4-12292021_091205.xml","form_type":"4"}},{"id":2916311,"issuer":{"id":5337,"kind":"organization","name":"CAPRICOR THERAPEUTICS, INC."},"owners":[{"id":69869,"kind":"person","name":"Musket David B","position":1,"cik":"0001310611","reported_name":"Musket David B","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2021-01-06T22:02:50.000Z","date":"2021-01-04","kind":"grant","acquired":true,"shares":96126,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares vest 1/48th of the first day of each month, commencing February 1, 2021, until the stock option becomes fully vested and exercisable. The option is subject to early exercise and, therefore, all or any part of the option can be exercised at any time. If the reporting person elects to take advantage of the early exercise feature and purchase shares prior to the vesting of such shares, the shares will be deemed restricted stock and will be subject to a repurchase option in favor of the Issuer if the reporting person's service to the Issuer terminates prior to vesting."}],"balance_after":96126,"derivative":{"exercise_price":3.74,"expiration_date":"2031-01-04","underlying":"Common Stock","underlying_shares":96126},"source":{"system":"sec-edgar","filing":"0001104659-21-001583","document":"tm211849-2_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1133869/000110465921001583/tm211849-2_4seq1.xml","form_type":"4"}},{"id":3116934,"issuer":{"id":5337,"kind":"organization","name":"CAPRICOR THERAPEUTICS, INC."},"owners":[{"id":69869,"kind":"person","name":"Musket David B","position":1,"cik":"0001310611","reported_name":"Musket David B","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2020-06-09T20:33:40.000Z","date":"2020-06-05","kind":"grant","acquired":true,"shares":109000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares vest 1/48th of the first day of each month, commencing March 1, 2020, until the stock option becomes fully vested and exercisable. The following stock option grant was approved by the Board on February 12, 2020 under the 2020 Plan, contingent upon stockholder approval of the 2020 Plan, which was obtained on June 5, 2020. The option is subject to early exercise and, therefore, all or any part of the option can be exercised at any time. If the reporting person elects to take advantage of the early exercise feature and purchase shares prior to the vesting of such shares, the shares will be deemed restricted stock and will be subject to a repurchase option in favor of the Issuer if the reporting person's service to the Issuer terminates prior to vesting."}],"balance_after":109000,"derivative":{"exercise_price":1.39,"expiration_date":"2030-06-05","underlying":"Common Stock","underlying_shares":109000},"source":{"system":"sec-edgar","filing":"0001104659-20-071415","document":"tm2022128-2_4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1133869/000110465920071415/tm2022128-2_4.xml","form_type":"4"}},{"id":3271100,"issuer":{"id":5337,"kind":"organization","name":"CAPRICOR THERAPEUTICS, INC."},"owners":[{"id":69869,"kind":"person","name":"Musket David B","position":1,"cik":"0001310611","reported_name":"Musket David B","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2020-02-14T23:08:22.000Z","date":"2020-02-12","kind":"disposition_to_issuer","acquired":false,"shares":15455,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The reported transactions involved the repricing of outstanding options, resulting in the deemed cancellation of the \"old\" options and the grant of replacement options, with a new exercise price of $1.39 per share."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The stock option award is fully vested and exercisable."}],"balance_after":0,"derivative":{"exercise_price":3.7,"expiration_date":"2022-04-27","underlying":"Common Stock","underlying_shares":15455},"source":{"system":"sec-edgar","filing":"0001104659-20-022099","document":"tm208086d2_4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":14,"url":"https://www.sec.gov/Archives/edgar/data/1133869/000110465920022099/tm208086d2_4.xml","form_type":"4"}},{"id":3271099,"issuer":{"id":5337,"kind":"organization","name":"CAPRICOR THERAPEUTICS, INC."},"owners":[{"id":69869,"kind":"person","name":"Musket David B","position":1,"cik":"0001310611","reported_name":"Musket David B","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2020-02-14T23:08:22.000Z","date":"2020-02-12","kind":"disposition_to_issuer","acquired":false,"shares":1401,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The reported transactions involved the repricing of outstanding options, resulting in the deemed cancellation of the \"old\" options and the grant of replacement options, with a new exercise price of $1.39 per share."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The stock option award is fully vested and exercisable."}],"balance_after":0,"derivative":{"exercise_price":3.7,"expiration_date":"2023-03-06","underlying":"Common Stock","underlying_shares":1401},"source":{"system":"sec-edgar","filing":"0001104659-20-022099","document":"tm208086d2_4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":13,"url":"https://www.sec.gov/Archives/edgar/data/1133869/000110465920022099/tm208086d2_4.xml","form_type":"4"}},{"id":3271098,"issuer":{"id":5337,"kind":"organization","name":"CAPRICOR THERAPEUTICS, INC."},"owners":[{"id":69869,"kind":"person","name":"Musket David B","position":1,"cik":"0001310611","reported_name":"Musket David B","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2020-02-14T23:08:22.000Z","date":"2020-02-12","kind":"disposition_to_issuer","acquired":false,"shares":4750,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The reported transactions involved the repricing of outstanding options, resulting in the deemed cancellation of the \"old\" options and the grant of replacement options, with a new exercise price of $1.39 per share."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The stock option award is fully vested and exercisable."}],"balance_after":0,"derivative":{"exercise_price":57.8,"expiration_date":"2025-03-03","underlying":"Common Stock","underlying_shares":4750},"source":{"system":"sec-edgar","filing":"0001104659-20-022099","document":"tm208086d2_4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":12,"url":"https://www.sec.gov/Archives/edgar/data/1133869/000110465920022099/tm208086d2_4.xml","form_type":"4"}},{"id":3271097,"issuer":{"id":5337,"kind":"organization","name":"CAPRICOR THERAPEUTICS, INC."},"owners":[{"id":69869,"kind":"person","name":"Musket David B","position":1,"cik":"0001310611","reported_name":"Musket David B","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2020-02-14T23:08:22.000Z","date":"2020-02-12","kind":"disposition_to_issuer","acquired":false,"shares":4645,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The reported transactions involved the repricing of outstanding options, resulting in the deemed cancellation of the \"old\" options and the grant of replacement options, with a new exercise price of $1.39 per share."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The stock option award is fully vested and exercisable."}],"balance_after":0,"derivative":{"exercise_price":31.2,"expiration_date":"2026-06-02","underlying":"Common Stock","underlying_shares":4645},"source":{"system":"sec-edgar","filing":"0001104659-20-022099","document":"tm208086d2_4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":11,"url":"https://www.sec.gov/Archives/edgar/data/1133869/000110465920022099/tm208086d2_4.xml","form_type":"4"}},{"id":3271096,"issuer":{"id":5337,"kind":"organization","name":"CAPRICOR THERAPEUTICS, INC."},"owners":[{"id":69869,"kind":"person","name":"Musket David B","position":1,"cik":"0001310611","reported_name":"Musket David B","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2020-02-14T23:08:22.000Z","date":"2020-02-12","kind":"disposition_to_issuer","acquired":false,"shares":3606,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The reported transactions involved the repricing of outstanding options, resulting in the deemed cancellation of the \"old\" options and the grant of replacement options, with a new exercise price of $1.39 per share."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"856 of the shares will vest 1/48th on the first day of each month, commencing February 1, 2017, until the stock option becomes fully vested and exercisable. The remaining 2,750 shares will vest 1/12th on the first day of each month, commencing February 1, 2017, with the last month vesting on December 31, 2017. The option is subject to early exercise and, therefore, all or any part of the option can be exercised at any time. If the reporting person elects to take advantage of the early exercise feature and purchase shares prior to the vesting of such shares, the shares will be deemed restricted stock and will be subject to a repurchase option in favor of the Registrant if the reporting person's service to the Registrant terminates prior to vesting."}],"balance_after":0,"derivative":{"exercise_price":25.5,"expiration_date":"2027-01-03","underlying":"Common Stock","underlying_shares":3606},"source":{"system":"sec-edgar","filing":"0001104659-20-022099","document":"tm208086d2_4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/1133869/000110465920022099/tm208086d2_4.xml","form_type":"4"}},{"id":3271095,"issuer":{"id":5337,"kind":"organization","name":"CAPRICOR THERAPEUTICS, INC."},"owners":[{"id":69869,"kind":"person","name":"Musket David B","position":1,"cik":"0001310611","reported_name":"Musket David B","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2020-02-14T23:08:22.000Z","date":"2020-02-12","kind":"disposition_to_issuer","acquired":false,"shares":3800,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The reported transactions involved the repricing of outstanding options, resulting in the deemed cancellation of the \"old\" options and the grant of replacement options, with a new exercise price of $1.39 per share."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"1,050 of the shares will vest 1/48th on the first day of each month, commencing February 1, 2018, until the stock option becomes fully vested and exercisable.  The remaining 2,750 shares will vest 1/12th on the first day of each month, commencing February 1, 2018, with the last month vesting on December 31, 2018. The option is subject to early exercise and, therefore, all or any part of the option can be exercised at any time. If the reporting person elects to take advantage of the early exercise feature and purchase shares prior to the vesting of such shares, the shares will be deemed restricted stock and will be subject to a repurchase option in favor of the Registrant if the reporting person's service to the Registrant terminates prior to vesting."}],"balance_after":0,"derivative":{"exercise_price":15.7,"expiration_date":"2028-01-02","underlying":"Common Stock","underlying_shares":3800},"source":{"system":"sec-edgar","filing":"0001104659-20-022099","document":"tm208086d2_4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1133869/000110465920022099/tm208086d2_4.xml","form_type":"4"}},{"id":3271094,"issuer":{"id":5337,"kind":"organization","name":"CAPRICOR THERAPEUTICS, INC."},"owners":[{"id":69869,"kind":"person","name":"Musket David B","position":1,"cik":"0001310611","reported_name":"Musket David B","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2020-02-14T23:08:22.000Z","date":"2020-02-12","kind":"disposition_to_issuer","acquired":false,"shares":8750,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The reported transactions involved the repricing of outstanding options, resulting in the deemed cancellation of the \"old\" options and the grant of replacement options, with a new exercise price of $1.39 per share."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"3,000 of the shares were vested on the date of grant. The remaining 5,750 shares will vest 1/48th on the first day of each month, commencing September 1, 2019, until the stock option becomes fully vested and exercisable.  The option is subject to early exercise and, therefore, all or any part of the option can be exercised at any time. If the reporting person elects to take advantage of the early exercise feature and purchase shares prior to the vesting of such shares, the shares will be deemed restricted stock and will be subject to a repurchase option in favor of the Registrant if the reporting person's service to the Registrant terminates prior to vesting."}],"balance_after":0,"derivative":{"exercise_price":3.25,"expiration_date":"2029-08-08","underlying":"Common Stock","underlying_shares":8750},"source":{"system":"sec-edgar","filing":"0001104659-20-022099","document":"tm208086d2_4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1133869/000110465920022099/tm208086d2_4.xml","form_type":"4"}},{"id":3271093,"issuer":{"id":5337,"kind":"organization","name":"CAPRICOR THERAPEUTICS, INC."},"owners":[{"id":69869,"kind":"person","name":"Musket David B","position":1,"cik":"0001310611","reported_name":"Musket David B","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2020-02-14T23:08:22.000Z","date":"2020-02-12","kind":"grant","acquired":true,"shares":15455,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The reported transactions involved the repricing of outstanding options, resulting in the deemed cancellation of the \"old\" options and the grant of replacement options, with a new exercise price of $1.39 per share."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"1,050 of the shares will vest 1/48th on the first day of each month, commencing February 1, 2018, until the stock option becomes fully vested and exercisable.  The remaining 2,750 shares will vest 1/12th on the first day of each month, commencing February 1, 2018, with the last month vesting on December 31, 2018. The option is subject to early exercise and, therefore, all or any part of the option can be exercised at any time. If the reporting person elects to take advantage of the early exercise feature and purchase shares prior to the vesting of such shares, the shares will be deemed restricted stock and will be subject to a repurchase option in favor of the Registrant if the reporting person's service to the Registrant terminates prior to vesting."}],"balance_after":15455,"derivative":{"exercise_price":1.39,"expiration_date":"2022-04-27","underlying":"Common Stock","underlying_shares":15455},"source":{"system":"sec-edgar","filing":"0001104659-20-022099","document":"tm208086d2_4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1133869/000110465920022099/tm208086d2_4.xml","form_type":"4"}},{"id":3271092,"issuer":{"id":5337,"kind":"organization","name":"CAPRICOR THERAPEUTICS, INC."},"owners":[{"id":69869,"kind":"person","name":"Musket David B","position":1,"cik":"0001310611","reported_name":"Musket David B","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2020-02-14T23:08:22.000Z","date":"2020-02-12","kind":"grant","acquired":true,"shares":1401,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The reported transactions involved the repricing of outstanding options, resulting in the deemed cancellation of the \"old\" options and the grant of replacement options, with a new exercise price of $1.39 per share."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The stock option award is fully vested and exercisable."}],"balance_after":1401,"derivative":{"exercise_price":1.39,"expiration_date":"2023-03-06","underlying":"Common Stock","underlying_shares":1401},"source":{"system":"sec-edgar","filing":"0001104659-20-022099","document":"tm208086d2_4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1133869/000110465920022099/tm208086d2_4.xml","form_type":"4"}},{"id":3271091,"issuer":{"id":5337,"kind":"organization","name":"CAPRICOR THERAPEUTICS, INC."},"owners":[{"id":69869,"kind":"person","name":"Musket David B","position":1,"cik":"0001310611","reported_name":"Musket David B","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2020-02-14T23:08:22.000Z","date":"2020-02-12","kind":"grant","acquired":true,"shares":4750,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The reported transactions involved the repricing of outstanding options, resulting in the deemed cancellation of the \"old\" options and the grant of replacement options, with a new exercise price of $1.39 per share."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The stock option award is fully vested and exercisable."}],"balance_after":4750,"derivative":{"exercise_price":1.39,"expiration_date":"2025-03-03","underlying":"Common Stock","underlying_shares":4750},"source":{"system":"sec-edgar","filing":"0001104659-20-022099","document":"tm208086d2_4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1133869/000110465920022099/tm208086d2_4.xml","form_type":"4"}},{"id":3271090,"issuer":{"id":5337,"kind":"organization","name":"CAPRICOR THERAPEUTICS, INC."},"owners":[{"id":69869,"kind":"person","name":"Musket David B","position":1,"cik":"0001310611","reported_name":"Musket David B","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2020-02-14T23:08:22.000Z","date":"2020-02-12","kind":"grant","acquired":true,"shares":4645,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The reported transactions involved the repricing of outstanding options, resulting in the deemed cancellation of the \"old\" options and the grant of replacement options, with a new exercise price of $1.39 per share."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The stock option award is fully vested and exercisable."}],"balance_after":4645,"derivative":{"exercise_price":1.39,"expiration_date":"2026-06-02","underlying":"Common Stock","underlying_shares":4645},"source":{"system":"sec-edgar","filing":"0001104659-20-022099","document":"tm208086d2_4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1133869/000110465920022099/tm208086d2_4.xml","form_type":"4"}},{"id":3271089,"issuer":{"id":5337,"kind":"organization","name":"CAPRICOR THERAPEUTICS, INC."},"owners":[{"id":69869,"kind":"person","name":"Musket David B","position":1,"cik":"0001310611","reported_name":"Musket David B","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2020-02-14T23:08:22.000Z","date":"2020-02-12","kind":"grant","acquired":true,"shares":3606,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The reported transactions involved the repricing of outstanding options, resulting in the deemed cancellation of the \"old\" options and the grant of replacement options, with a new exercise price of $1.39 per share."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"856 of the shares will vest 1/48th on the first day of each month, commencing February 1, 2017, until the stock option becomes fully vested and exercisable. The remaining 2,750 shares will vest 1/12th on the first day of each month, commencing February 1, 2017, with the last month vesting on December 31, 2017. The option is subject to early exercise and, therefore, all or any part of the option can be exercised at any time. If the reporting person elects to take advantage of the early exercise feature and purchase shares prior to the vesting of such shares, the shares will be deemed restricted stock and will be subject to a repurchase option in favor of the Registrant if the reporting person's service to the Registrant terminates prior to vesting."}],"balance_after":3606,"derivative":{"exercise_price":1.39,"expiration_date":"2027-01-03","underlying":"Common Stock","underlying_shares":3606},"source":{"system":"sec-edgar","filing":"0001104659-20-022099","document":"tm208086d2_4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1133869/000110465920022099/tm208086d2_4.xml","form_type":"4"}},{"id":3271088,"issuer":{"id":5337,"kind":"organization","name":"CAPRICOR THERAPEUTICS, INC."},"owners":[{"id":69869,"kind":"person","name":"Musket David B","position":1,"cik":"0001310611","reported_name":"Musket David B","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2020-02-14T23:08:22.000Z","date":"2020-02-12","kind":"grant","acquired":true,"shares":3800,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The reported transactions involved the repricing of outstanding options, resulting in the deemed cancellation of the \"old\" options and the grant of replacement options, with a new exercise price of $1.39 per share."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"1,050 of the shares will vest 1/48th on the first day of each month, commencing February 1, 2018, until the stock option becomes fully vested and exercisable.  The remaining 2,750 shares will vest 1/12th on the first day of each month, commencing February 1, 2018, with the last month vesting on December 31, 2018. The option is subject to early exercise and, therefore, all or any part of the option can be exercised at any time. If the reporting person elects to take advantage of the early exercise feature and purchase shares prior to the vesting of such shares, the shares will be deemed restricted stock and will be subject to a repurchase option in favor of the Registrant if the reporting person's service to the Registrant terminates prior to vesting."}],"balance_after":3800,"derivative":{"exercise_price":1.39,"expiration_date":"2028-01-02","underlying":"Common Stock","underlying_shares":3800},"source":{"system":"sec-edgar","filing":"0001104659-20-022099","document":"tm208086d2_4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1133869/000110465920022099/tm208086d2_4.xml","form_type":"4"}},{"id":3271087,"issuer":{"id":5337,"kind":"organization","name":"CAPRICOR THERAPEUTICS, INC."},"owners":[{"id":69869,"kind":"person","name":"Musket David B","position":1,"cik":"0001310611","reported_name":"Musket David B","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2020-02-14T23:08:22.000Z","date":"2020-02-12","kind":"grant","acquired":true,"shares":8750,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The reported transactions involved the repricing of outstanding options, resulting in the deemed cancellation of the \"old\" options and the grant of replacement options, with a new exercise price of $1.39 per share."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"3,000 of the shares were vested on the date of grant. The remaining 5,750 shares will vest 1/48th on the first day of each month, commencing September 1, 2019, until the stock option becomes fully vested and exercisable.  The option is subject to early exercise and, therefore, all or any part of the option can be exercised at any time. If the reporting person elects to take advantage of the early exercise feature and purchase shares prior to the vesting of such shares, the shares will be deemed restricted stock and will be subject to a repurchase option in favor of the Registrant if the reporting person's service to the Registrant terminates prior to vesting."}],"balance_after":8750,"derivative":{"exercise_price":1.39,"expiration_date":"2029-08-08","underlying":"Common Stock","underlying_shares":8750},"source":{"system":"sec-edgar","filing":"0001104659-20-022099","document":"tm208086d2_4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1133869/000110465920022099/tm208086d2_4.xml","form_type":"4"}},{"id":3335290,"issuer":{"id":5337,"kind":"organization","name":"CAPRICOR THERAPEUTICS, INC."},"owners":[{"id":69869,"kind":"person","name":"Musket David B","position":1,"cik":"0001310611","reported_name":"Musket David B","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Warrants (Right to Buy)","published_at":"2019-12-20T00:34:48.000Z","date":"2019-12-17","kind":"grant","acquired":true,"shares":20391,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The Reporting Person on December 17, 2019, purchased 20,391 shares of the common stock of Capricor Therapeutics, Inc. (the \"Issuer\"), and accompanying amount of warrants to purchase up to an aggregate of 20,391 shares of the Issuer's common stock, at a combined purchase price of $1.226 per share of common stock and accompanying warrant, for a total cost of approximately US$25,000."}],"balance_after":20391,"derivative":{"exercise_price":1.1,"exercise_date":"2019-12-17","expiration_date":"2024-12-17","underlying":"Common Stock","underlying_shares":20391},"source":{"system":"sec-edgar","filing":"0001104659-19-074514","document":"tm1926719d2_4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1133869/000110465919074514/tm1926719d2_4.xml","form_type":"4"}},{"id":3335289,"issuer":{"id":5337,"kind":"organization","name":"CAPRICOR THERAPEUTICS, INC."},"owners":[{"id":69869,"kind":"person","name":"Musket David B","position":1,"cik":"0001310611","reported_name":"Musket David B","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-12-20T00:34:48.000Z","date":"2019-12-17","kind":"grant","acquired":true,"shares":20391,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The Reporting Person on December 17, 2019, purchased 20,391 shares of the common stock of Capricor Therapeutics, Inc. (the \"Issuer\"), and accompanying amount of warrants to purchase up to an aggregate of 20,391 shares of the Issuer's common stock, at a combined purchase price of $1.226 per share of common stock and accompanying warrant, for a total cost of approximately US$25,000."}],"balance_after":22891,"source":{"system":"sec-edgar","filing":"0001104659-19-074514","document":"tm1926719d2_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1133869/000110465919074514/tm1926719d2_4.xml","form_type":"4"}},{"id":3442566,"issuer":{"id":5337,"kind":"organization","name":"CAPRICOR THERAPEUTICS, INC."},"owners":[{"id":69869,"kind":"person","name":"Musket David B","position":1,"cik":"0001310611","reported_name":"Musket David B","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2019-08-10T01:00:20.000Z","date":"2019-08-08","kind":"grant","acquired":true,"shares":8750,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"3,000 of the shares shall vest immediately. The remaining 5,750 shares will vest 1/48th on the first day of each month, commencing September 1, 2019, until the stock option becomes fully vested and exercisable. However, the option is subject to early exercise and, therefore, all or any part of the option can be exercised at any time. If the reporting person elects to take advantage of the early exercise feature and purchase shares prior to the vesting of such shares, the shares will be deemed restricted stock and will be subject to a repurchase option in favor of the Registrant if the reporting person's service to the Registrant terminates prior to vesting."}],"balance_after":8750,"derivative":{"exercise_price":3.25,"expiration_date":"2029-08-08","underlying":"Common Stock","underlying_shares":8750},"source":{"system":"sec-edgar","filing":"0001144204-19-039000","document":"tv527331_form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1133869/000114420419039000/tv527331_form4.xml","form_type":"4"}},{"id":4107966,"issuer":{"id":5337,"kind":"organization","name":"CAPRICOR THERAPEUTICS, INC."},"owners":[{"id":69869,"kind":"person","name":"Musket David B","position":1,"cik":"0001310611","reported_name":"Musket David B","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2018-01-04T22:01:55.000Z","date":"2018-01-02","kind":"grant","acquired":true,"shares":38000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"10,500 of the shares will vest 1/48th on the first day of each month, commencing February 1, 2018, until the stock option becomes fully vested and exercisable. The remaining 27,500 shares will vest 1/12 on the first day of each month, commencing February 1, 2018, with the last month vesting on December 31, 2018. However, the option is subject to early exercise and, therefore, all or any part of the option can be exercised at any time. If the reporting person elects to take advantage of the early exercise feature and purchase shares prior to the vesting of such shares, the shares will be deemed restricted stock and will be subject to a repurchase option in favor of the Registrant if the reporting person's service to the Registrant terminates prior to vesting."}],"balance_after":38000,"derivative":{"exercise_price":1.57,"expiration_date":"2028-01-02","underlying":"Common Stock","underlying_shares":38000},"source":{"system":"sec-edgar","filing":"0001144204-18-000857","document":"tv482715_4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1133869/000114420418000857/tv482715_4.xml","form_type":"4"}},{"id":4325089,"issuer":{"id":5337,"kind":"organization","name":"CAPRICOR THERAPEUTICS, INC."},"owners":[{"id":69869,"kind":"person","name":"Musket David B","position":1,"cik":"0001310611","reported_name":"Musket David B","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2017-05-11T18:32:36.000Z","date":"2017-05-09","kind":"purchase","acquired":true,"shares":25000,"price":3.1,"value":77500.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The Reporting Person entered into a Subscription Agreement with Capricor Therapeutics, Inc. (the \"Issuer\") pursuant to which the Reporting Person, on May 5, 2017  purchased an aggregate of 25,000 shares of the Issuer's common stock at a purchase price of $3.10 per share for total cash proceeds of approximately US$77,500."}],"balance_after":25000,"source":{"system":"sec-edgar","filing":"0001144204-17-026397","document":"v466674_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1133869/000114420417026397/v466674_4.xml","form_type":"4"}},{"id":4503378,"issuer":{"id":5337,"kind":"organization","name":"CAPRICOR THERAPEUTICS, INC."},"owners":[{"id":69869,"kind":"person","name":"Musket David B","position":1,"cik":"0001310611","reported_name":"Musket David B","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2017-01-05T02:42:17.000Z","date":"2017-01-03","kind":"grant","acquired":true,"shares":36060,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"8,560 of the shares will vest 1/48th on the first day of each month, commencing February 1, 2017, until the stock option becomes fully vested and exercisable. The remaining 27,500 shares will vest 1/12 on the first day of each month, commencing February 1, 2017, with the last month vesting on December 31, 2017. However, the option is subject to early exercise and, therefore, all or any part of the option can be exercised at any time. If the reporting person elects to take advantage of the early exercise feature and purchase shares prior to the vesting of such shares, the shares will be deemed restricted stock and will be subject to a repurchase option in favor of the Registrant if the reporting person's service to the Registrant terminates prior to vesting."}],"balance_after":36060,"derivative":{"exercise_price":2.55,"exercise_date":"2017-01-03","expiration_date":"2027-01-03","underlying":"Common Stock","underlying_shares":36060},"source":{"system":"sec-edgar","filing":"0001144204-17-000701","document":"v456176_4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1133869/000114420417000701/v456176_4.xml","form_type":"4"}}]}